Related Experiment Video
Updated: Jul 17, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel lymph node biopsy improves staging in early cervical cancer
Anne-Sophie Bats1, Denys Clément, Florence Larousserie
1Service de Chirurgie Gynécologique, Hôpital Européen Georges Pompidou, 20 rue Leblanc 75015 Paris, France.
Gynecologic Oncology
|January 16, 2007
Summary
Sentinel lymph node (SLN) biopsy in early cervical cancer accurately identifies nodes in unusual locations and detects metastases. This technique improves staging for patients with early-stage disease.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Nuclear Medicine Imaging
Background:
- Early cervical cancer staging is crucial for treatment planning.
- Sentinel lymph node (SLN) biopsy is an evolving technique for accurate nodal staging.
- Understanding SLN distribution and micrometastasis prevalence is key.
Purpose of the Study:
- To describe sentinel lymph node (SLN) distribution in early cervical cancer.
- To determine the prevalence of SLN micrometastases.
- To confirm SLN detection rates and negative predictive value.
Main Methods:
- Prospective study of 25 early cervical cancer patients.
- Preoperative lymphoscintigraphy with technetium-99m and intraoperative gamma probe detection.
- Intraoperative patent blue dye injection and radical iliac dissection.
- Hematoxylin-eosin-saffron staining and immunohistochemistry for SLN analysis.
Main Results:
- 85% of SLNs were located in the inter-iliac region.
- SLNs were found in unusual locations (para-aortic, common iliac) in 36% of patients.
- One metastasis and one micrometastasis were detected in SLNs; no positive non-sentinel nodes with negative SLNs were observed.
Conclusions:
- Sentinel lymph node (SLN) biopsy identifies SLNs in unexpected sites in 36% of early cervical cancer patients.
- SLN metastasis was present in 8% of patients, indicating improved staging accuracy.
- Larger studies are needed to establish the clinical impact of SLN biopsy.
